← Leaderboards
Douglas J. Jolly
Advantagene, Inc
$482,896
Attributed
$482,896
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $269K · FY2007–12$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$482,896 · 2
By mechanism
R43$482,896 · 2
Top collaborators
No co-investigators on record.
Most similar at Advantagene, Inc
Same institution · by research overlap
- Estuardo Aguilar-Cordova$12,245,489
- Laura K Aguilar$1,149,301
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSafetyVectorViralEnvironmentMalignant NeoplasmsResearch PersonnelTumorBaseCharacteristicsAffectCancer CellCancer PatientCancer TherapyBrain NeoplasmsAdverse EffectsAdenovirusesChemotherapeutic AgentCessation Of LifeAppearanceAdverse Drug EffectChemotherapyChemotherapy-Oncologic ProcedureCell Proliferation